PPBT 241220 5.00C (PPBT241220C5000) Stock Options, News & Quotes

US OptionsDetailed Quotes

PPBT241220C5000

Watchlist

0.36
-1.49-80.54%

15min DelayClose Dec 4 16:00 ET

1.40High0.36Low

Intraday

5D
Daily

News

Purple Biotech Signs Securities Purchase Agreement
TipRanks11:58 ET
Purple Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
SEC11:42 ET · Announcements
PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy
Zacks Dec 3 10:35 ET
Express News | Purple Biotech Announces $2.8M Offering Of 472,668 ADS
BenzingaDec 3 08:26 ET
Purple Biotech to Sell 472,668 ADSs at $6.00 in Registered Direct Offering
TipRanksDec 3 08:25 ET
ADRs Advance; Purple Biotech Ltd. Climbs 150%
Dow JonesDec 2 16:31 ET

Comments

Ken2win

Dec 3 07:51

$Purple Biotech (PPBT.US)$ all in today

PaulG

Dec 3 07:41

$Purple Biotech (PPBT.US)$ Lol..a previous press release said they had enough money until late 2025.. .then today...another offering at 6.00. Liars!

Angeler

Dec 3 07:35

$Purple Biotech (PPBT.US)$ buy the dip 🌹❤️💗

standalee31

Dec 3 07:25

Naughty, naughty

$Purple Biotech (PPBT.US)$

Jaguar8

Dec 3 07:23

NEWS

$Purple Biotech (PPBT.US)$
Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares
Tuesday, 3rd December at 8:23 am
REHOVOT, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and drug resistance, today announced that it has entered into a definitive agreement for the purchase and sale of 472,...